Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Rhee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea). High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease. 960

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease. Source: International Congress 2017 – COPD and weaning Year: 2017 Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Chronic pain in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008